Post date January 8, 2024 Experience Olema Pharmaceuticals $150 million at-the-market offering The shares are listed on the Nasdaq Global Select Market
Post date January 2, 2024 Experience Myers Industries $350 million acquisition of Signature Systems We are advising Myers Industries on the acquisition
Post date December 21, 2023 Experience MSCI acquisition of Fabric RQ We are advising MSCI on the acquisition
Post date December 13, 2023 Experience Coty $400 million tender offers The offers apply to certain senior notes due 2026
Post date December 11, 2023 Experience Credo Technology Group Holding $201.3 million follow-on offering We advised Credo on the SEC-registered offering
Post date December 7, 2023 Experience Enova International $400 million senior notes offering The high-yield notes are due 2028
Post date November 22, 2023 Experience Smith+Nephew acquisition of CartiHeal We are advising Smith+Nephew on the acquisition
Post date November 17, 2023 Experience Polaris $500 million debut senior notes offering We advised Polaris on its inaugural investment-grade notes offering
Post date November 17, 2023 Experience Service Properties Trust $1 billion senior secured notes offering We advised SVC on its high-yield secured notes offering
Post date November 16, 2023 Experience Amneal Pharmaceuticals $2.35 billion term loan We advised Amneal Pharmaceuticals on a new term loan